|
LineaGen, Inc. is a content-based biomarker discovery company focused on the
commercialization of novel, patentable diagnostic tests that will enable highly
effective personalized medicine and healthcare in a variety of key areas. By using
individuals' genetic profiles to diagnose health issues and conditions earlier and
more accurately, LineaGen diagnostics will support early treatment and greatly
improve patients' chances for positive results. be able to reliably predict those
individuals' response to various treatments. One of LineaGen's core competitive
advantages is its access to an unmatched biomarker discovery research platform
that has been used to help the University of Utah identify more disease-related
genes than any other institution in the world. LineaGen is working to develop a
diversified portfolio of novel biomarkers for the development of new diagnostic
tests, and to strategically license its intellectual property to commercial partners
for the development of new therapeutic treatments. |
